SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-330403
Filing Date
2021-11-16
Accepted
2021-11-15 21:15:05
Documents
14
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d49862d8k.htm   iXBRL 8-K 24969
2 EX-99.1 d49862dex991.htm EX-99.1 71270
6 GRAPHIC g49862g10u10.jpg GRAPHIC 14895
  Complete submission text file 0001193125-21-330403.txt   248169

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rani-20211115.xsd EX-101.SCH 2916
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rani-20211115_lab.xml EX-101.LAB 18123
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rani-20211115_pre.xml EX-101.PRE 11421
7 EXTRACTED XBRL INSTANCE DOCUMENT d49862d8k_htm.xml XML 3370
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 211413830
SIC: 2834 Pharmaceutical Preparations